Dynamic rRNA methylation regulates translation in the hematopoietic system and is essential for stem cell fitness
Self-renewal and differentiation are at the basis of hematopoiesis. Although it is known that tight regulation of translation is vital for hematopoietic stem cells' (HSC) biology, the mechanisms underlying translation regulation across the hematopoietic system remain obscure. Here, we reveal a novel mechanism of translation regulation in the hematopoietic hierarchy, which is mediated by rRNA methylation dynamics. Using ultralow-input ribosome profiling, we characterized cell-type-specific translation capacity during erythroid differentiation. We found that translation efficiency (TE) changes progressively with differentiation and can distinguish between discrete cell populations, as well as define differentiation trajectories. To reveal the underlying mechanism, we performed comprehensive mapping of the most abundant rRNA modification, 2'-O-methyl (2'OMe). We found that, such as TE, 2'OMe dynamics followed a distinct trajectory during erythroid differentiation. Genetic perturbation of individual 2'OMe sites demonstrated their distinct roles in modulating proliferation and differentiation. By combining CRISPR screening, molecular, and functional analyses, we identified a specific methylation site, 28S-Gm4588, which is progressively lost during differentiation, as a key regulator of HSC self-renewal. We showed that low methylation at this site led to translational skewing, mediated mainly by codon frequency, which promoted differentiation. Functionally, HSC with diminished 28S-Gm4588 methylation exhibited impaired self-renewal capacity ex vivo, and loss of fitness in vivo in bone marrow transplants. Extending our findings beyond the hematopoietic system, we also found distinct dynamics of 2'OMe profiles during differentiation of non-HSC. Our findings reveal rRNA methylation dynamics as a general mechanism for cell-type-specific translation, required for cell function and differentiation.
Authors
- Ola Karmi (ORCID: https://orcid.org/0000-0002-8684-7039)
- Cornelius Pauli (ORCID: https://orcid.org/0000-0001-8506-1571)
- Daphna Nachmani (ORCID: https://orcid.org/0000-0002-8489-9986)
- Adi Reches
- Sivan Ben Dror
- Carsten Müller‐Tidow (ORCID: https://orcid.org/0000-0002-7166-5232)
- Alexander van Oudenaarden (ORCID: https://orcid.org/0000-0002-9442-3551)
- J. Wexler
- Sagiv Shifman (ORCID: https://orcid.org/0000-0003-4071-5361)
- Virginie Marchand (ORCID: https://orcid.org/0000-0002-8537-1139)
- Yoav Livneh (ORCID: https://orcid.org/0000-0002-0434-4201)
- Michael VanInsberghe (ORCID: https://orcid.org/0000-0001-8418-4393)
- Yudit Halperin (ORCID: https://orcid.org/0009-0009-7378-4946)
- Nina Mayorek (ORCID: https://orcid.org/0000-0002-5989-4884)
- Maram Arafat (ORCID: https://orcid.org/0000-0003-3857-1071)
- Yuri Motorin (ORCID: https://orcid.org/0000-0002-8018-334X)
- Galya Monderer‐Rothkoff
- Ofri Rabany
- Noga Ussishkin (ORCID: https://orcid.org/0009-0006-6357-7212)
- Nikolai Romanovski
- Widad Mâmmer Bouhou
- Hadar Aharoni levitanus
- Maayan Livneh Golany
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- German Cancer Research Center (DE)
- Hebrew University of Jerusalem (IL)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- University Medical Center Utrecht (NL)
- Netherlands Heart Institute (NL)
- Concern Foundation (US)
- Hubrecht Institute for Developmental Biology and Stem Cell Research (NL)
- Ingénierie Moléculaire et Physiopathologie Articulaire (FR)
- Weizmann Institute of Science (IL)
- Heidelberg University (US)
- Université de Lorraine (FR)
Publication Details
- Journal
- Blood
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1182/blood.2024028300
- Citations
- 1
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.81